What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
Johnstone
E C
EC
Department of Clinical Pharmacology, Oxford University, Oxford, UK.
Kerr
D J
DJ
D014408:Biomarkers, Tumor / Q000235:genetics*; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods*; D018714:Radiotherapy, Adjuvant
D014408:Biomarkers, Tumor